December 14, 2020
December 14, 2020 – The U.S. FDA has approved an additional, shorter infusion time for Ocrevus®
(ocrelizumab). Manufactured by Roche, the drug is indicated to treat adults who have
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
December 14, 2020
December 14, 2020 – The U.S. FDA has granted Emergency Use Authorization (EUA) to a vaccine from Pfizer and BioNTech to prevent COVID-19 caused by the SARS-CoV-2 virus in individuals
December 11, 2020
December 11, 2020 - The U.S. Food and Drug Administration (FDA) granted Pfizer and BioNTech an
Emergency Use Authorization (EUA) for the companies’ jointly developed COVID-19 vaccine.
December 9, 2020
December 9, 2020 – AvKARE of Pulaski, TN, has voluntarily recalled one lot of Sildenafil 100mg tablets and
one lot of Trazodone 100mg tablets after the two products were inadvertently packaged
December 9, 2020
December 9, 2020 – Torrent Pharmaceuticals has voluntarily recalled one lot of Anagrelide Capsules, USP, following the product’s failure in a dissolution test that is part of routine quality testing.
December 4, 2020
December 4, 2020 –The U.S. FDA has approved a label update for Merck’s Januvia® (sitagliptin), Janumet®
(sitagliptin/metformin hydrochloride), and Janumet® XR (sitagliptin/metformin
December 4, 2020
December 4, 2020 – The U.S. FDA has approved an expanded indication for Saxenda® (liraglutide) injection 3mg, manufactured by Novo Nordisk. First FDA approved in 2014 to provide chronic weight
December 3, 2020
December 3, 2020 – The U.S. FDA has approved OrladeyoTM (berotralstat), manufactured by BioCryst Pharmaceuticals, to provide prophylaxis (prevention) of hereditary angioedema (HAE)